Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

24

Revenue 2017

Eylea

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Eylea was produced by Bayer.

UK doctors call on NHS to use Avastin for wet AMD

UK doctors call on NHS to use Avastin for wet AMD Currently, GMC guidance and European drug licensing laws say that Lucentis (ranibizumab), from Novartis and Roche, and Bayer/Regeneron's Eylea(aflibercept) - that are approved to treat wet AMD - should be ... Eylea because it is around a tenth of the

NICE recommends Ozurdex for diabetic eye condition

NICE recommends Ozurdex for diabetic eye condition d Eylea (aflibercept), which both have licences for DMO.

Fresh approval for Roche's Lucentis as competition heats up

Fresh approval for Roche's Lucentis as competition heats up Roche's drug is being challenged in the market by Bayer's Eylea (aflibercept) as well as newer entrants such as Allergan's Ozurdex (intravitreal dexamethasone).

Novartis launches another localised NHS eye service in UK

Novartis launches another localised NHS eye service in UK The drug was the dominant force in wet AMD treatment for some time, although is now facing a challenge from Bayer's Eylea (aflibercept), which was recommended in 2013. ... The update was significant for Novartis as Eylea is recommended as a monthly

Germany's IQWiG delivers bad news for Bayer’s Eylea

Germany's IQWiG delivers bad news for Bayer’s Eylea Germany's cost-effectiveness watchdog has concluded that Bayer's Eylea provides no additional benefit over Novartis' rival drug Lucentis in patients with a diabetes-related eye disorder. ... The ruling could mean Bayer may struggle to get favourable

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....
Cell and gene therapy
Tackling the manufacturing cost and complexity challenges...

Infographics